FindTrial
Sign In

Construction and effect evaluation of management model for rational use of proton pump inhibitors led by clinical pharmacists

Construction and effect evaluation of management model for rational use of proton pump inhibitors led by clinical pharmacists

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111139
Enrollment
Unknown
Registered
2025-10-27
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rational use of PPI

Interventions

Intervention group:Pre audit system and clinical pharmacist intervention
Control group:None

Sponsors

Liangxiang Hospital of Beijing Fangshan District
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Information on the use of PPIs in hospitalized patients;

Exclusion criteria

Exclusion criteria: 1. Patients bring their own PPIs for oral medication; 2. The medical record information is incomplete.

Design outcomes

Primary

MeasureTime frame
PPIs usage intensity, medical order qualification rate;—

Secondary

MeasureTime frame
The usage rate and amount of PPIs, as well as the incidence of adverse reactions to PPIs;—

Countries

China

Contacts

Public ContactSong Ning

Liangxiang Hospital of Beijing Fangshan District

sn1977850@163.com+86 10 8135 6407

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026